Concepedia

Residual Plasmid Testing

Residual Plasmid Testing is a methodological procedure in biopharmaceutical development that quantifies trace amounts of plasmid DNA remaining in a final product to ensure compliance with safety and regulatory release criteria.

2

Publications

31

Citations

11

Authors

2

Institutions

Publications per year

2017–2026

0

Parents

Publications

2

1–3 of 2

Authors

11

  1. ZC
    Zu-Huan Chen

    Second Military Medical University, China

    1 publications · 11 citations

    1

    h-index

  2. KW
    Kaihui Wang

    Fudan University, China

    1 publications · 11 citations

    1

    h-index

  3. KS
    Ke Shi

    Henan Agricultural University, China

    1 publications · 11 citations

    1

    h-index

  4. LZ
    Lanju Zhang

    AbbVie (United States), United States

    1 publications · 20 citations

    1

    h-index

  5. HY
    Harry Yang

    Altimmune (United States), United States

    1 publications · 20 citations

    1

    h-index

1–5 of 11

Institutions

2

  1. Altimmune (United States)

    Gaithersburg, United States

    1 h-index

    1 publications

    20 citations

  2. Second Military Medical University

    Shanghai, China

    1 h-index

    8 publications

    88 citations

  3. ID Genomics (United States)

    Seattle, United States

    1 publications

    10 citations

  4. University of Guelph

    Guelph, Canada

    1 publications

    10 citations

1–4 of 2

Venues

  1. Vaccine

    2 publications · 31 citations

    2

    h-index

  2. Autoimmunity

    1 publications · 10 citations

1–2